(Q34583643)

3 August 2017

1 reference

title

Adverse effects of atypical antipsychotics : differential risk and clinical implications (English)

1 reference

3 August 2017

Peter M Haddad

1

1 reference

3 August 2017

Sonu G Sharma

series ordinal

2

1 reference

3 August 2017

language of work or name

1 reference

1 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

21

1 reference

3 August 2017

11

1 reference

3 August 2017

911-936

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200721110-00004

3 August 2017

0 references

cites work

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

1 reference

12 December 2020

Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials

1 reference

12 December 2020

Factors which can make patients difficult to treat.

1 reference

12 December 2020

Neuroleptic malignant syndrome induced by atypical antipsychotics

1 reference

12 December 2020

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

1 reference

12 December 2020

The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia

1 reference

12 December 2020

Post-marketing surveillance: a UK/European perspective

1 reference

12 December 2020

Prescription-event monitoring--recent progress and future horizons

1 reference

12 December 2020

Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone

1 reference

12 December 2020

Prevention of clozapine-induced neutropenia by pretreatment with lithium

1 reference

12 December 2020

The role of lifestyle interventions and weight management in schizophrenia

1 reference

12 December 2020

Aripiprazole: profile on efficacy and safety

1 reference

12 December 2020

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

12 December 2020

Spontaneous ejaculations and neuroleptics

1 reference

12 December 2020

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

1 reference

12 December 2020

A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia

1 reference

12 December 2020

Prospective study of tardive dyskinesia incidence in the elderly

1 reference

12 December 2020

Prospective study of tardive dyskinesia in the elderly: rates and risk factors

1 reference

12 December 2020

Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement

1 reference

12 December 2020

Electrocardiographic changes induced by phenothiazine drugs

1 reference

12 December 2020

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria

1 reference

12 December 2020

Treatment of tardive dyskinesia

1 reference

12 December 2020

Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences

1 reference

12 December 2020

Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results

1 reference

12 December 2020

Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline.

1 reference

12 December 2020

Clozapine-related seizures

1 reference

12 December 2020

Priapism from quetiapine overdose: first report and proposal of mechanism

1 reference

12 December 2020

Metabolic and lifestyle issues and severe mental illness--new connections to well-being?

1 reference

12 December 2020

Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review

1 reference

12 December 2020

Lithium and clozapine-induced neutropenia/agranulocytosis

1 reference

12 December 2020

Real progress--the patient's perspective.

1 reference

12 December 2020

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

1 reference

12 December 2020

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

1 reference

12 December 2020

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

1 reference

12 December 2020

Incidence of tardive dyskinesia: five-year data from a prospective study

1 reference

12 December 2020

Risk of death in elderly users of conventional vs. atypical antipsychotic medications

1 reference

12 December 2020

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

1 reference

12 December 2020

Schizophrenia practice guidelines: international survey and comparison.

1 reference

12 December 2020

Tardive dyskinesia associated with olanzapine.

1 reference

12 December 2020

Misuse of anticholinergic drugs by people with serious mental illness.

1 reference

12 December 2020

Sexual disturbances during clozapine and haloperidol treatment for schizophrenia

1 reference

12 December 2020

Clozapine withdrawal rebound psychosis

1 reference

12 December 2020

Antidepressant discontinuation syndromes

1 reference

12 December 2020

High plasma prolactin levels after long-term neuroleptic treatment

1 reference

12 December 2020

Recurrent Priapism During Treatment With Clozapine and Olanzapine

1 reference

12 December 2020

Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics

1 reference

12 December 2020

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

12 December 2020

Risperidone versus olanzapine for schizophrenia

1 reference

12 December 2020

Prevalence of tardive dyskinesia in elderly samples

1 reference

12 December 2020

The disease burden associated with overweight and obesity

1 reference

12 December 2020

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

1 reference

12 December 2020

Antipsychotics and diabetes: review of non-prospective data.

1 reference

12 December 2020

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

12 December 2020

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study

1 reference

12 December 2020

Atypical antipsychotics and weight gain--a systematic review

1 reference

12 December 2020

Clozapine-induced hypersalivation

1 reference

12 December 2020

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs

1 reference

12 December 2020

Tardive dyskinesia with quetiapine.

1 reference

12 December 2020

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

Olanzapine-induced reversible priaprism: a case report

1 reference

12 December 2020

The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists

1 reference

12 December 2020

Atypical antipsychotics in the EPS-vulnerable patient

1 reference

12 December 2020

Quetiapine : A Review of its Use in Schizophrenia

1 reference

12 December 2020

Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.

1 reference

12 December 2020

Olanzapine-induced priapism

1 reference

12 December 2020

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study

1 reference

12 December 2020

Prolactin elevation with ziprasidone.

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

Sertindole for schizophrenia

1 reference

12 December 2020

Supersensitivity and clozapine withdrawal

1 reference

12 December 2020

Neuroleptic discontinuation syndromes

1 reference

12 December 2020

Chlorpromazine in nonpsychotic patients with pulmonary tuberculosis

1 reference

12 December 2020

Atypical antipsychotics and risk of cerebrovascular accidents.

1 reference

12 December 2020

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

1 reference

12 December 2020

Neuroleptic malignant syndrome without the use of neuroleptics

1 reference

12 December 2020

Sexual dysfunction: the unspoken side effect of antipsychotics

1 reference

12 December 2020

Clozapine-induced priapism

1 reference

12 December 2020

Spontaneous and tardive dyskinesias: clinical and laboratory studies

1 reference

12 December 2020

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

1 reference

12 December 2020

Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine

1 reference

12 December 2020

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia

1 reference

12 December 2020

Hyperprolactinemia and male sexual dysfunction

1 reference

12 December 2020

Safety of amisulpride (Solian): a review of 11 clinical studies

1 reference

12 December 2020

Tardive dyskinesia in affective disorders.

1 reference

12 December 2020

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

1 reference

12 December 2020

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

12 December 2020

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

1 reference

12 December 2020

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.

1 reference

12 December 2020

Risk of hip fracture in patients with a history of schizophrenia.

1 reference

12 December 2020

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

1 reference

12 December 2020

A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance

1 reference

12 December 2020

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine

1 reference

12 December 2020

Reflux oesophagitis and clozapine

1 reference

12 December 2020

Association of venous thromboembolism and clozapine

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

12 December 2020

Death from clozapine-induced constipation: case report and literature review.

1 reference

12 December 2020

Clozapine-associated diabetes

1 reference

12 December 2020

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

12 December 2020

Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients

1 reference

12 December 2020

Weight changes during clozapine treatment

1 reference

12 December 2020

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

1 reference

12 December 2020

Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients

1 reference

12 December 2020

The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?

1 reference

12 December 2020

Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia

1 reference

12 December 2020

Adverse effects of antipsychotics as outcome measures

1 reference

12 December 2020

Olanzapine-associated diabetes mellitus

1 reference

12 December 2020

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

12 December 2020

Haemolytic anemia, jaundice and diabetes mellitus following chlorpromazine therapy.

1 reference

12 December 2020

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

Risperidone-induced priapism

1 reference

12 December 2020

Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.

1 reference

12 December 2020

Sexual side effects of novel antipsychotic medications

1 reference

12 December 2020

Diabetes and its prevention: pragmatic solutions for people with schizophrenia.

1 reference

12 December 2020

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

12 December 2020

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

1 reference

12 December 2020

Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

12 December 2020

Antipsychotic medications and seizures

1 reference

12 December 2020

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

1 reference

12 December 2020

A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.

1 reference

12 December 2020

The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients

1 reference

12 December 2020

Myocarditis and cardiomyopathy associated with clozapine

1 reference

12 December 2020

Clozapine-related tardive dyskinesia.

1 reference

12 December 2020

The relationship between patient satisfaction and treatment outcomes in schizophrenia

1 reference

12 December 2020

Dopamine antagonists and the development of breast cancer

1 reference

12 December 2020

A model of anticholinergic activity of atypical antipsychotic medications

1 reference

12 December 2020

Clozapine efficacy in tardive dyskinesia in schizophrenic patients

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

12 December 2020

Effect of clozapine on human serum prolactin levels

1 reference

12 December 2020

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia

1 reference

12 December 2020

Risperidone-induced tardive dyskinesia

1 reference

12 December 2020

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

1 reference

12 December 2020

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

1 reference

12 December 2020

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

1 reference

12 December 2020

Muscarinic mechanisms of antipsychotic atypicality

1 reference

12 December 2020

Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient

1 reference

12 December 2020

Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.

1 reference

12 December 2020

Sexual dysfunction in patients taking conventional antipsychotic medication

1 reference

12 December 2020

Weight change with atypical antipsychotics in the treatment of schizophrenia

1 reference

12 December 2020

Unexplained deaths during chlorpromazine therapy

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods

1 reference

12 December 2020

'Schizophrenia and Diabetes 2003' Expert Consensus Meeting, Dublin, 3-4 October 2003: consensus summary.

1 reference

12 December 2020

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

1 reference

12 December 2020

Clozapine withdrawal-emergent dystonias and dyskinesias: a case series

1 reference

12 December 2020

Declining frequency of neuroleptic malignant syndrome in a hospital population

1 reference

12 December 2020

Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

1 reference

12 December 2020

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

1 reference

12 December 2020

A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning

1 reference

12 December 2020

The effects of clozapine on tardive dyskinesia

1 reference

12 December 2020

A study of serum prolactin levels in schizophrenia: comparison of males and females

1 reference

12 December 2020

Priapism associated with psychotropic drugs

1 reference

12 December 2020

Clozapine--a new antipsychotic agent.

1 reference

12 December 2020

Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal

1 reference

12 December 2020

Societal and personal costs of obesity

1 reference

12 December 2020

Clozapine and hypertension: a chart review of 82 patients.

1 reference

12 December 2020

Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.

1 reference

12 December 2020

Antipsychotic medication and seizures: a review

1 reference

12 December 2020

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 reference

12 December 2020

Clozapine and sudden death

1 reference

12 December 2020

Adverse reactions with beta-adrenoceptor blocking drugs. An update

1 reference

12 December 2020

Prolactin levels during long-term risperidone treatment in children and adolescents

1 reference

12 December 2020

Risperidone-associated diabetes mellitus: a pharmacovigilance study

1 reference

12 December 2020

Neuroleptic malignant syndrome

1 reference

12 December 2020

A systematic review of atypical antipsychotic drugs in schizophrenia.

1 reference

12 December 2020

Neuroendocrine response to antipsychotics: effects of drug type and gender.

1 reference

12 December 2020

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Differential effect of clozapine on weight: a controlled study

1 reference

12 December 2020

Aripiprazole and neuroleptic malignant syndrome

1 reference

12 December 2020

Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

10.2165/00023210-200721110-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference